Author:
Seo Byung-Kwan,Ryu Hee-Kyoung,Park Yeon-Cheol,Huh Jeong-Eun,Baek Yong-Hyeon
Funder
Ministry of Education, Science and Technology
Korea Health Industry Development Institute
Subject
Drug Discovery,Pharmacology
Reference31 articles.
1. Bone markers and osteoporosis therapy;Bandeira;Arq. Bras. Endocrinol. Metabol.,2014
2. Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives;Baron;J. Clin. Endocrinol. Metab.,2012
3. Bobis, S., Jarocha, D., Majka, M., 2006. Mesenchymal stem cells: characteristics and clinical applications. Folia histochemica et cytobiologica/Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 44, pp. 215–230.
4. von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation;Bonewald;Calcif. Tissue Int.,2003
5. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025;Burge;J. Bone Miner. Res.: Off. J. Am. Soc. Bone Miner. Res.,2007
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献